The active drug, alfuzosin, is used to treat symptoms of an enlarged prostate (benign prostatic hyperplasia, or BPH). Deacylated alfuzosin, also known as alfuzosin aminopropyl impurity (Alfuzosin EP Impurity D), has no therapeutic use as a drug itself; it is an inactive metabolite and an impurity standard used in pharmaceutical development and quality control.
Deacylated alfuzosin
| API Name | Alfuzosin |
|---|---|
| CAS No | 76362-29-3 |
| Molecular Formula | C14H21N5O2 |
| Molecular Weight | 291.35 g/mol |
| Synonyms | 2-N-(3-aminopropyl)-6,7-dimethoxy-2-N-methylquinazoline-2,4-diamine |
Zoho Contact Form
"*" indicates required fields